Skip to main content

Table 1 Study Criteria

From: Oestrogen-deficiency induces bone loss by modulating CD14+ monocyte and CD4+ T cell DR3 expression and serum TL1A levels

Inclusion Criteria Exclusion Criteria
Attending for first bone density scan Recent fracture (in the past 3 months)
Adult History of corticosteroid use (except inhaled or topical)
Female Anti-TNF therapy
Post-Menopausal Patients with known seropositive rheumatoid arthritis, inflammatory bowel disease
Recent history of continuous treatment with bisphosphonate, calcitonin, Strontium ranelate or parathyroid hormone (i.e. for more than 3 months)
Patients with known primary hyperparathyroidism
Currently taking part in another study